Assessment of Mechanisms of Improved Wound Healing

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

644

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2013

Conditions
Burns
Interventions
PROCEDURE

Stable Isotope Infusion study

Stable isotope infusion study to be done following each surgery. Tagged isotopes to assess uptake into blood and tissues. Includes collection of blood and tissues (muscle)

DRUG

Insulin High Dose

Insulin IV administered continuously throughout hospitalization until wounds are 95% healed.

DRUG

oxandrolone

Oxandrolone given daily throughout hospitalization until 95% wound healing.

DRUG

Propranolol

Propranolol to be given daily throughout hospitalization until 95% wound healing.

DRUG

Growth Hormone

Recombinant Human Growth hormone to be administered daily until 95% wound healing.

DRUG

Insulin Low Dose

Insulin administered IV until 95% wound healing

DRUG

IGF-1/IGFBP-3

Insulin Like Growth Factor-1/Insulin like Growth Factor Binding Protein 3 administered until 95% wound healing

DRUG

Itraconazole

Itraconazole administered until 95% wound healing

DRUG

Growth Hormone and Propranolol

Growth Hormone and Propranolol given until 95% wound healing

DRUG

Oxandrolone and Propranolol

Oxandrolone and Propranolol

DRUG

Placebo or Control

Administration of Placebo or Control until 95% wound healing

Trial Locations (1)

77550

University of Texas Medical Branch, Galveston

All Listed Sponsors
collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

The University of Texas Medical Branch, Galveston

OTHER

NCT00673309 - Assessment of Mechanisms of Improved Wound Healing | Biotech Hunter | Biotech Hunter